Bristol-Myers Squibb (NY, USA) have announced that they will be acquiring Celgene (NJ, USA) this year for a cost of $74 billion.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Find out what Naidong Weng (Janssen Research and Development) has to say about the future of bioanalytical outsourcing, in this expert interview.
Find out what Marco Michi (Aptuit) has to say about the future of bioanalytical outsourcing, in this expert interview.
Find out what Kevin Vernarec (QPS) thinks about how outsourcing might change in the future in this expert interview.
Find out what Song Li (Frontage) has to say about the future of bioanalytical outsourcing, in this video interview.
The Good Clinical Laboratory Practice accreditation will enable the company to extend its proteomic services to the analysis of clinical trial samples.
Lonza (Basel, Switzerland) announce the launch of four new services to expand their early phase biopharmaceutical drug development.
Mersana Therapeutics (MA, USA), a biopharmaceutical company, announce FDA clearance of IND application for their new drug, XMT-1536.
CiToxLab North America has purchased a new facility, which will focus on bioanalysis and biomarker services in Montreal, Canada.